APOE and Alzheimer disease: We hypothesized that middle-aged individuals carrying APOE risk alleles would exhibit some alterations in brain function (more intense in case of carriers of double, APOE and PICALM, risk) that resemble AD symptoms, i.e., reduced EEG signal complexity, slowing of brainwaves and disrupted functional connectivity as observed through either EEG or fMRI.